Inceptua Pharma Archives - Inceptua Group

Elevar Therapeutics Inc. Announces Licensing Agreement with Inceptua Group for Commercialization of Apealea® (Paclitaxel Micellar) in Europe

Elevar Therapeutics Inc. Announces Licensing Agreement with Inceptua Group for Commercialization of Apealea® (Paclitaxel Micellar) in Europe December 28 2020, Elevar Therapeutics, Inc, a fully integrated biopharmaceutical company built…

Inceptua GroupDecember 28, 2020

Featured Inceptua Pharma Update

Helping get orphan drugs to patients quicker

Across Europe there is disparity in the average time for new drugs to be approved and accessible to patients. There are a number of factors delaying these processes. Stuart Bell,…

Stuart BellOctober 7, 2020

Featured Inceptua Pharma Update

Commercialize and partner successfully in Europe and the Middle East

Dr. Stefan Fraenkel, Executive Vice President, Inceptua Pharma Understand how to commercialize via partnering in Europe and other markets outside of the USA. Dr. Stefan Fraenkel, Executive Vice President, Commercial…

Stefan FraenkelNovember 1, 2018